We often look to third-party rankings and ratings-based platforms to help guide our decision-making. What are the best restaurants in Manhattan, or what are the top colleges in the US? In each of these cases, there are probably a few list-curators that come to mind – including one that continues to draw scrutiny, in large … Read more
Prior to the Covid-19 pandemic, employers looked upon their insurance carrier as their be-all and end-all when it came to employee benefits. Now, however, the focus has shifted to providing employees with a diverse set of solutions for specific conditions, with an eye towards affordability, cost reductions and improved outcomes. “If you go back pre-Covid, … Read more
We launched MedCity Pivot during the pandemic when the ability to change and do something completely different was a major strength. Now that the public health emergency is due to end and we are entering an endemic phase, it was important to change the format of what we discuss. With that in mind, MedCity Pivot … Read more
Insurers are pushing back after the Centers for Medicare & Medicaid Services (CMS) issued its final rule on the Medicare Advantage Risk Adjustment Data Validation (RADV) program Monday. The rule will lead to stricter audits on Medicare Advantage plans. Currently, CMS regulators have been reviewing a small group of beneficiaries’ medical records and comparing them … Read more
Hormone therapies are well established in breast cancer treatment, working by blocking or reducing levels of hormones that feed tumor growth. If the disease progresses, the next line of therapy includes an injectable drug that specifically targets the estrogen receptor on cancer cells. Several big pharmaceutical companies have been trying to develop drugs that work … Read more
A new startup co-incubated by ARCH Venture Partners spirit General Catalyst launched last week with $203 million in Series A funding. The New York-based company, called Paradigm, is focused on improving patients’ access to clinical research. Its financing was led by ARCH and General Catalyst, with participation from F-Prime Capital, GV, LUX Capital, Mubadala Capital, … Read more
“You look at the mental health industry today, and it’s remarkable how little measurement is occurring. less than 20% of providers are collecting any data at all, even though we now know from decades of research that measuring care and using that data to inform care makes outcomes dramatically better.” Those were the words spoken … Read more
Cell and gene therapies rely on engineered viruses to deliver them to their cellular destinations. While the progress of these types of medicines is evident in a growing number of FDA product approvals, one limiting factor facing these therapies is the availability of viral vectors. Most cell and gene therapy developers turn to a contract … Read more
In partnership with Accolade and TeleMed2U, Blue Shield of California released its Virtual Blue health benefits plan Monday. The plan, effective April 1, gives members access to virtual primary, behavioral and specialty care, in addition to in-person care. “What we’ve done is tied a really robust virtual care offering to our tandem [preferred provider organization] … Read more
Ciox — a company focused on increasing access to medical records — recently partnered with Virginia-based non-profit health system Sentara Healthcare to pilot a tool that makes it easier for expectant mothers to access their health records. San Francisco-based Data addict acquired Ciox in a $7 trillion deal that closed in 2021. One of Ciox’s … Read more